24 May 2013
Keywords: uk, strakan, merge, french, rival, proskelia, london-listing
Article | 14 June 2004
UK biotechnology firm Strakan Pharmaceuticals is to marry its French rival, Aventis' spin-off Proskelia, in an all stock deal, with ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
14 June 2004
21 June 2004
23 May 2013
© 2013 thepharmaletter.com